The Annexure

What the ground filed.

A desk of BSE disclosures — every listed company, sliced the way you need it.

Data as of 9 September 2026

Fundraising

Issue of Securities

Draft letter of Offer

The filing

Draft letter of Offer

Company
Natco Pharma Ltd · BSE 524816
Filed
9 September 2026, 17:51 IST
BSE category
Company Update / Issue of Securities
Tag
Fundraising · selected
Source
Open the filing on BSE →

Why it led

  • First Fundraising from this company — not seen in the 71 trading days on record
  • Small cap · NIFTY 500
  • 2 filings today

Selected by the ranker from 38 filings that day. Each line above is a component of that score, not a comment on the filing.

How often this tag appears

314 of 87,933 filings in the published window carry Fundraising · 0.36%

Around it

Also filed by Natco Pharma Ltd on 9 September 2026

Most recent filings from Natco Pharma Ltd

The company

Natco Pharma Ltd

BSE 524816 · NSE NATCOPHARM · ISIN INE987B01026 · Group A · Active

HealthcareHealthcarePharmaceuticals & BiotechnologyPharmaceuticals

Full figures, price and filing history for Natco Pharma Ltd →